Rebeca Infante et al.
FULL PAPERS
835, 757, 691, 621 cmÀ1: HR-MS: m/z=333.1101, calcd. for
C19H18O4 +Na+: 333.1097; HPLC (Chiralpak AD-H,
hexane:2-propanol=90:10, 1 mLminÀ1, l=220 nm): tR =
23.5 min for enantiomer R, tR =33.0 min for enantiomer S.
2H), 7.56–7.61 (m, 2H), 7.79–7.94 (m, 4H), 8.29 (s, 1H);
13C NMR (100 MHz, CDCl3): d=13.8, 63.6, 73.3, 86.3, 87.1,
122.0, 123.9, 125.6, 126.3, 126.5, 127.6, 128.2, 128.3 (2), 128.5,
128.9, 132.0 (2), 132.9, 133.3, 136.7, 171.8; IR (neat): n=
3474, 3059, 2981, 2231, 1731, 1235, 1092, 1038, 858, 820, 756,
690 cmÀ1; HR-MS: m/z=353.1145, calcd. for C22H18O3 +
Na+: 353.1148; HPLC (Chiralpak AD-H, hexane:2-propa-
nol=99:01, 1 mLminÀ1, l=220 nm): tR =89.9 min for enan-
tiomer R, tR =97.4 min for enantiomer S.
(S)-Ethyl
2-(p-chlorophenyl)-2-hydroxy-4-phenylbut-3-
ynoate (4f): This compound was obtained from 2f (53.0 mg,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (ethyl acetate/hexane=1/45); color-
less oil; yield: 71%; [a]20: À26.0 (c 0.8, CHCl3). 1H NMR
(400 MHz, CDCl3): d=1.D25 (t, J=7.1 Hz, 3H), 4.23 (dq, J1 =
10.7 Hz, J2 =7.1 Hz, 1H), 4.32 (dq, J1 =10.7 Hz, J2 =7.1 Hz,
1H), 4.35 (br s, 1H, OH), 7.31–7.40 (m, 5H), 7.50–7.54 (m,
2H), 7.70 (d, J=8.6 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d=13.8, 63.7, 72.7, 86.3, 86.8, 121.7, 127.8 (2), 128.3 (2),
128.4 (2), 129.0, 131.9 (2), 134.7, 138.0, 171.5; IR (neat): n=
3474, 2982, 2231, 1733, 1489, 1240, 1089, 108, 1015, 835, 756,
(R)-Ethyl
2-(2-furyl)-2-hydroxy-4-phenylbut-3-ynoate
(4j): This compound was obtained from 2j (42.0 mg,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (dichloromethane/hexane=1/2); col-
1
orless oil; yield: 60%; [a]20: +7.2 (c 0.6, CHCl3). H NMR
(400 MHz, CDCl3): d=1.3D0 (t, J=7.1 Hz, 3H), 4.29 (s, 1H,
OH), 4.30–4.43 (m, 2H), 6.39 (dd, J1 =3.3 Hz, J2 =1.8 Hz,
1H), 6.70 (dd, J1 =3.3 Hz, J2 =0.9 Hz, 1H), 7.31–7.38 (m,
3H), 7.42 (dd, J1 =1.8 Hz, J2 =0.9 Hz, 1H), 7.50–7.54 (m,
2H); 13C NMR (100 MHz, CDCl3): d=13.9, 63.9, 68.5, 84.7,
85.3, 109.4, 110.5, 121.6, 128.3 (2), 129.1, 132.0 (2), 143.4,
151.2, 169.8; IR (neat): n=3476, 2923, 2853, 2233, 1732,
1489, 1446, 1244, 1206, 1070, 1065, 1039, 1007, 760, 748,
694 cmÀ1; HR-MS: m/z=293.0783, calcd. for C16H14O4 +
Na+: 293.0784; HPLC (Chiralpak AD-H, hexane:2-propa-
nol=99:01, 1 mLminÀ1, l=220 nm): tR =57.0 min for enan-
tiomer S, tR =84.0 min for enantiomer R.
690, 611 cmÀ1
;
HR-MS: m/z=337.0615, calcd. for
C18H15ClO3 +Na+; 337.0602; HPLC (Chiralcel OD,
hexane:2-propanol=99:01, 0.6 mLminÀ1, l=220 nm): tR =
33.4 min for enantiomer R, tR =37.9 min for enantiomer S.
(R)-Ethyl 2-hydroxy-4-phenyl-2-o-tolylbut-3-ynoate (4g):
This compound was obtained from 2g (43.0 mg, 0.25 mmol)
and 3a (117 mL, 1.05 mmol), and purified by flash chroma-
tography (ethyl acetate/hexane=1/45); colorless oil; yield:
87%; [a]2D0: À2.4 (c 1.7, CHCl3); 1H NMR (400 MHz,
CDCl3): d=1.27 (t, J=7.1 Hz, 3H), 2.39 (s, 3H), 4.10 (s,
1H, OH), 4.28 (dq, J1 =10.7 Hz, J2 =7.1 Hz, 1H), 4.39 (dq,
J1 =10.7 Hz, J2 =7.1 Hz, 1H), 7.16–7.20 (m, 1H), 7.22–7.30
(m, 2H), 7.31–7.39 (m, 3H), 7.49–7.56 (m, 2H), 7.97–8.02
(m, 1H); 13C NMR (100 MHz, CDCl3): d=13.8, 19.9, 63.3,
74.5, 87.3, 87.8, 121.9, 125.7, 128.3 (2), 128.7, 128.9, 128.9,
131.8 (3), 136.1, 136.6, 172.3; IR (neat): n=3475, 2981, 2226,
1729, 1239, 1072, 1054, 1033, 754, 725, 690, 650 cmÀ1; HR-
MS: m/z=317.1151, calcd. for C19H18O3 +Na+: 317.1148;
HPLC (Chiralpak AD-H, hexane:2-propanol=80:20,
1 mLminÀ1, l=220 nm): tR =8.9 min for enantiomer S, tR =
10.1 min for enantiomer R.
(S)-Ethyl 2-hydroxy-2-methyl-4-phenylbut-3-ynoate (4k):
This compound was obtained from 2k (29 mL, 0.25 mmol)
and 3a (117 mL, 1.05 mmol), and purified by flash chroma-
tography (ethyl acetate/hexane=1/45); colorless oil; yield:
66%; [a]20: +28.6 (c 0.9, CHCl3), (lit.[9] [a]2D0: À15.3, c 0.38,
CHCl3, 9D2% ee for R). H NMR (400 MHz, CDCl3): d=1.35
(t, J=7.1 Hz, 3H), 1.78 (s, 3H), 3.64 (s, 1H, OH), 4.33 (q,
J=7.1 Hz, 2H), 7.27–7.35 (m, 3H), 7.40–7.46 (m, 2H);
13C NMR (100 MHz, CDCl3): d=14.0, 27.1, 62.9, 68.3, 83.8,
88.4, 122.0, 128.2 (2), 128.7, 131.8 (2), 172.7; IR (neat): n=
3476, 2987, 2238, 1840, 1733, 1246, 1146, 1123, 1015, 756,
(R)-Ethyl 2-hydroxy-2-(o-methoxyphenyl)-4-phenylbut-3-
ynoate (4h): This compound was obtained from 2h (52.0 mg,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (ethyl acetate/hexane=1/45); color-
691, 615 cmÀ1
;
HR-MS: m/z=241.0829, calcd. for
C13H14O3 +Na+: 241.0835; HPLC (Chiralcel OD, hexane:2-
propanol=99:01, 0.6 mLminÀ1, l=220 nm): tR =33.0 min
for enantiomer S, tR =41.6 min for enantiomer R.
1
less oil; yield: 92%; [a]2D0: +19.0 (c 2.2, CHCl3). H NMR
(S)-Ethyl
2-hydroxy-2-isopropyl-4-phenylbut-3-ynoate
(400 MHz, CDCl3): d=1.25 (t, J=7.1 Hz, 3H), 3.81 (s, 3H),
4.31 (q, J=7.1 Hz, 2H), 4.44 (br s, 1H, OH), 6.91 (dd, J1 =
8.2 Hz, J2 =0.9 Hz, 1H), 7.04 (td, J1 =7.5 Hz, J2 =1.1 Hz,
1H), 7.31–7.39 (m, 4H), 7.52–7.58 (m, 2H), 8.00 (dd, J1 =
7.6 Hz, J2 =1.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=
13.9, 55.4, 62.7, 72.6, 86.1, 87.4, 111.1, 120.7, 121.9, 127.8,
128.2 (2), 128.8, 129.3, 130.3, 131.8 (2), 156.3, 171.9; IR
(neat): n=3463, 2956, 2923, 2853, 2233, 1732, 1257, 1235,
1076, 1035, 759, 745, 693, 647 cmÀ1; HR-MS: m/z=333.1100,
calcd. for C19H18O4 +Na+: 333.1097; HPLC (Chiralpak AD-
H, hexane:2-propanol=90:10, 1 mLminÀ1, l=220 nm): tR =
25.0 min for enantiomer S, tR =48.7 min for enantiomer R.
(4l): This compound was obtained from 2l (38 mL,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (ethyl acetate/hexane=1/30); color-
1
less oil; yield: 50%; [a]20: +28.8 (c 0.8, CHCl3). H NMR
(400 MHz, CDCl3): d=0D.95 (d, J=6.8 Hz, 3H), 1.19 (d, J=
6.8 Hz, 3H), 1.36 (t, J=7.1 Hz, 3H), 2.32 (hept, J=6.8 Hz,
1H), 3.51 (s, 1H, OH), 4.29–4.41 (m, 2H), 7.27–7.35 (m,
3H), 7.42–7.48 (m, 2H); 13C NMR (100 MHz, CDCl3): d=
14.1, 16.3, 16.9, 37.0, 62.9, 74.7, 84.7, 87.6, 122.3, 128.2 (2),
128.5, 131.8 (2), 172.8; IR (neat): n=3501, 2971, 2935, 2873,
2228, 1840, 1731, 1244, 1146, 1027, 1013, 756, 723, 691 cmÀ1
;
HR-MS: m/z=269.1140, calcd. for C15H18O3 +Na+:
269.1148; HPLC (Chiralpak AD-H, hexane:2-propanol=
99:01, 1 mLminÀ1, l=220 nm): tR =13.6 min for enantiomer
R, tR =16.2 min for enantiomer S.
(S)-Ethyl
2-hydroxy-2-(naphthalen-2-yl)-4-phenylbut-3-
ynoate (4i): This compound was obtained from 2i (57.0 mg,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (ethyl acetate/hexane=1/45); color-
less oil; yield: 84%; [a]20: À44.8 (c 0.9, CHCl3). 1H NMR
(400 MHz, CDCl3): d=1.D25 (t, J=7.1 Hz, 3H), 4.24 (dq, J1 =
10.7 Hz, J2 =7.1 Hz, 1H), 4.36 (dq, J1 =10.7 Hz, J2 =7.1 Hz,
1H), 4.47 (s, 1H, OH), 7.33–7.43 (m, 3H), 7.49–7.55 (m,
(S)-Ethyl
2-hydroxy-2-phenethyl-4-phenylbut-3-ynoate
(4m): This compound was obtained from 2m (48 mL,
0.25 mmol) and 3a (117 mL, 1.05 mmol), and purified by
flash chromatography (ethyl acetate/hexane=1/45); color-
1
less oil; yield: 73%; [a]2D0: +36.9 (c 0.6, CHCl3). H NMR
2802
ꢃ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2012, 354, 2797 – 2804